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Abstract
Background: Implementation of high-quality national audits for perinatal mortality are needed to improve the
registration of all perinatal deaths and the identification of the causes of death. This study aims to evaluate the
implementation of a Regional Audit System for Stillbirth in Emilia-Romagna Region, Italy.
Methods: For each stillbirth (≥ 22 weeks of gestation, ≥ 500 g) occurred between January 1, 2014 to December 1,
2016 (n = 332), the same diagnostic workup was performed and a clinical record with data about mother and
stillborn was completed. Every case was discussed in a multidisciplinary local audit to assess both the cause of
death (ReCoDe classification) and the quality of care. Data were reviewed by the Regional Audit Group. Stillbirth
rates, causes of death and the quality of care were established for each case.
Results: Total stillbirth rate was 3.09 per 1000 births (332/107,528). Late stillbirth rate was 2.3 per 1000 (251/107,
087). Sixteen stillbirths were not registered by the Regional Birth Register. The most prevalent cause of death was
placental disorder (33.3%), followed by fetal (17.6%), cord (14.2%) and maternal disorders (7.6%). Unexplained cases
were 14%. Compared to local audits, the regional group attributed different causes of death in 17% of cases. At
multivariate analysis, infections were associated with early stillbirths (OR 3.38, CI95% 1.62–7.03) and intrapartum
cases (OR 6.64, CI95% 2.61–17.02). Placental disorders were related to growth restriction (OR 1.89, CI95% 1.06–3.36)
and were more frequent before term (OR 1.86, CI95% 1.11–3.15). Stillbirths judged possibly/probably preventable
with a different management (10.9%) occurred more frequently in non-Italian women and were mainly related to
maternal disorders (OR 6.64, CI95% 2.61–17.02).
Conclusions: Regional Audit System for Stillbirth improves the registration of stillbirth and allows to define the
causes of death. Moreover, sub-optimal care was recognized, allowing to identify populations which could benefit
from preventive measures.
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Background
Despite the large number of stillbirths (SB) occurring
every year [1, 2], global attention regarding this issue is
still insufficient. SB rates have declined more slowly
since 2000 than both maternal mortality and mortality
in children younger than 5 years [3]. Evidence suggests
that this gap can be narrowed by improving SB registra-
tions, data collection, investigation into the cause of
death, reducing social disadvantages and preventing
modified risk factors [4]. The Every Newborn Action
Plan (ENAP), endorsed by the United Nations, aims to
reduce the SB rate to 12 or fewer per 1000 births in
every country by 2030 [5]. Moreover, ENAP suggests all
countries to implement high quality national audits for
perinatal mortality, which translates into improvements
in quality of care, and the registration of all perinatal
deaths together with the identification of the cause of
death. Achieving these goals requires optimal diagnostic
testing and multidisciplinary review as part of a high-
quality perinatal mortality audit. According to a recent
report [6], countries that have implemented national
perinatal audit programs have achieved a reduction in
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SB rates. In addition, they have found an unacceptably
high proportion of cases with elements of sub-optimal
care. Despite the benefits of perinatal audit, still today
few Nations have implemented this scheme [7–9].
The existence of a large number of classification
systems does not always lead to the identification of
the cause of death, leaving many cases unexplained
[10]. Establishing an accurate cause of death is neces-
sary for parents to understand why their baby died,
help them to cope with the death and reduce the risk
of recurrence [11, 12].
A national perinatal audit program is currently
lacking in Italy. In Emilia-Romagna (ER), a region in
the North of the country, a Regional SB Audit Sys-
tem, managed by a multidisciplinary panel, has been
implemented since 2014 when the Regional Council
approved a resolution [13] to set up multidisciplinary
working groups, to perform local and regional peri-
natal audits.
This study describes the process of the SB audit
programme and presents the results after the first 3
years of implementation.
Methods
The process of audit
This audit project started after preparatory steps,
established between 2012 and 2014. An “ad hoc”
Commission designed the SB clinical record and the
complete diagnostic work-up for their use in every
Obstetrics Units. Then, a 2-h e-learning course was
offered to each professional (obstetricians, neonatol-
ogists and midwives) in every hospital to teach how
to complete stillborn records and how to carry out
diagnostic protocol. From 2014 to 2016 each case of
SB underwent this type of evaluation in all 29 hospi-
tals. The investigation is still ongoing.
The diagnosis of SB was based on the World Health
Organization (WHO) recommendation [14] and was de-
fined as fetal death at 22 weeks (154 days) of gestation or
greater, or birthweight of 500 g if the gestational age was
unknown. According to WHO’s recommendation, late
SB was defined as a fetus of 1000 g and/or 28 weeks of
gestation or greater and early SB as a fetus with a gesta-
tional age between 22 and 27.
Maternal information (demographics, obstetric his-
tory, presence of risk factors, antenatal investigations,
such as the number of medical examinations and ul-
trasounds) were collected. Date and gestational age at
delivery, birthweight, placenta weight, circumstances
of the SB, neonate external inspection carried out by
a neonatologist, were recorded together with the list
of tests done after the diagnosis of SB. Clinical re-
cords with data about mother and stillborn were
completed by the physician attending the women.
Diagnostic work-up included placental histology,
stillborn autopsy, microbiological evaluation (vaginal,
placental, fetal oropharyngeal swab/blood culture),
maternal blood tests, maternal serologic status for
infections, cytogenetic analysis (karyotype and, only
in specific case, CGH-array), flow cytometry for the
research of fetal-maternal haemorrhage and neonate
inspection by a neonatologist.
Primary and associated relevant conditions at death
were categorized using ReCoDe classification [15].
This system is based on 9 groups (fetus, cord, pla-
centa, amniotic fluid, uterus, mother, intrapartum,
trauma, unclassified). This classification was devel-
oped to better understand the clinically relevant con-
ditions for SB regardless of whether an underlying
cause was established. A comparison of different
classifications demonstrated that ReCoDe performs
better in terms of retaining important information
and ease of use, reporting also a low proportion of
unexplained cases [16].
Quality of care evaluation was also discussed ac-
cording to Confidential Enquiry into Stillbirths and
Deaths in Infancy (CESDI) grade [17]: (0: no sub-
standard care; 1: substandard care, different manage-
ment would have made no difference to outcome; 2:
substandard care, different management might have
made a difference to outcome; 3: substandard care,
different management would have reasonably been ex-
pected to have made a difference to outcome). A
death is considered potentially avoidable if the ab-
sence of the contributory factors may have prevented
it. Relevant Italian Guidelines are used to evaluate the
quality of care provided in relation to antenatal and
intrapartum care.
Six local area audits, covering the entire regional
territory, were organized twice a year to collect and
discuss cases. The multidisciplinary team included at
least an obstetrician, a neonatologist and a patholo-
gist. Each team was led by a local coordinator, who
recorded information on the results of investigations
and compiled the cause of death after the local audit.
He also checked every record and was responsible for
their final compilation.
Local coordinators together with other specialists,
such as microbiologists and geneticists, met every six
months as the central multidisciplinary audit group. This
group checked the number of SB comparing it to those
recorded in Birth certificates, registered the causes of
death and discussed cases defined as doubtful at the
local audit. In the case of incomplete information, local
coordinators were asked to do further investigations in
order to complete the database. Data on the result of re-
gional audit were managed and elaborated by the central
coordinator.
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The audit was paper-based. This assure the validity of
the information collected which can be easily checked
for each case by the local coordinators.
The present analysis of data was performed in agree-
ment with the Regional Council’s resolution [13] and re-
quested by the Birth Regional Commission in order to
evaluate perinatal care in the Region. A preliminary ana-
lysis was published in the annual report on pregnancy
care in Emilia-Romagna [18]. The study was approved
by the Institutional Review Board. Informed consent for
diagnostic work-up was not required because in Italy
diagnostic investigation is mandatory by law in case of
stillbirth (D.M. 7/2014 and D.P.C. 170/99). Patient and
fetus privacy was ensured during the phase of data col-
lection and analysis.
Definitions and statistical analysis
Fetal growth restriction (FGR) was defined as a birth-
weight below the 10th centile according to Italian Neo-
natal Study (INeS) chart [19] to categorize relevant con-
ditions at death and below the 5th centile for
multivariate analysis. Large for gestational age (LGA)
was defined as a birth-weight over the 95th centile.
Gestational age was estimated based on the last men-
strual period or on the first ultrasound examination, if
the last menstrual period was unknown or unreliable.
Placental insufficiency was defined as the presence of
histological features of functional impairment, such as
placental hypoplasia, infarcts covering at least 10% of
the placenta, diffuse villous hypoplasia, accelerated vil-
lous maturation, fetal vascular malperfusion and high
grade chronic villitis.
Placental abruptio was defined as cause of death if
there was clinical evidence of this condition and a histo-
pathologic finding of retroplacental hematoma.
The death was attributed to infection if there was evi-
dence of fetal infection, e.g. pathogen isolation in blood
culture/oropharyngeal swab and/or histological feature
of fetal inflammatory response.
Chorioamnionitis was defined as a cause of death if as-
sociated with funisitis at histological examination and/or
associated with clinical signs.
Maternal diabetes was the cause of death based on
histopathological signs of impaired glucose metabolism
and clinical signs of poor controlled maternal diabetes
(e.g. macrosomia, polidramnios, elevated blood sugar
despite the therapy, high glycate haemoglobin three
months after death). In the same way, hypertensive dis-
orders were defined as cause of death based on severity,
poor/absent clinical control and histopathological signs
of hypertension. Otherwise diabetes and hypertensive
disorders were simply recorded as associated conditions.
Cord constricting loop or knots were considered the
cause of death in those cases with histopathological
finding supporting this cause, such as thrombosis imme-
diately before and after the knot, or along the constrict-
ing loop.
A pre-pregnancy body mass index (BMI) ≥30 kg/m2 was
defined as obesity and ≥ 25 kg/m2 as overweight.
Information was collected in a database. Because of priv-
acy restrictions and to create a safe and secure environment
for audit participants, the database was anonymous.
In order to calculate risk factors, data of SB were com-
pared with livebirth data in the same period, using the
Regional Birth Register, which simultaneously collects
information about livebirths and stillbirths [18, 20, 21].
Data were analysed using statistical package StatView
(v 5.01.98; SAS Istitute Inc., Cary, NC). Categorical vari-
ables are expressed as frequencies and percentages. Odd
Risk (OR) with 95% confidence interval (CI) was com-
puted when appropriate. A p value of 0.05 or less was
considered significant. Multivariate analysis was per-
formed in order to verify associations between condition
of death and gestational age, birthweight and maternal/
fetal disorders. They were adjusted for known risk fac-
tors for adverse pregnancy outcomes such as BMI,
smoking, education level and maternal country of birth.
Results
From 2014 to 2016, 332 SB occurred out of a total of
107,528 births, with a SB rate of 3.1 per 1000. Of these
SB, 81 (24.4%) occurred before 28 weeks and 251 there-
after (75.6%), yielding a late SB rate of 2.3 per 1000. The
SB rate constantly declined between 2014 (3.2 per 1000)
and 2016 (3.0 per 1000). Seventeen cases (5.1%) oc-
curred after the onset of labour and were considered
intrapartum. Double-check led to the identification of 21
early SB which had not been recorded in the current
Birth Register.
Fifteen cases (4.5%) originated from multiple pregnan-
cies. Our population was heterogeneous in term of eth-
nicity: there were 190 (57.6%) Italian women, the others
were from North Africa (11.5%), East Europe (10.3%),
Sub-Saharan Africa (8.2%), Indian Subcontinent (7.6%)
and other countries (4.8%).
Complete diagnostic protocol was applied in the ma-
jority of cases. Placental examination and autopsy were
performed in 298 (90.3%) and 290 cases (87.8%),
respectively.
Clinical records were available for all cases but two,
seized by the judicial authority. For this reason, analyses
were conducted on a population of 330 SB.
Risk factors for SB are reported in Table 1. After 41
weeks, the risk of fetal demise was lower than in preterm
and full-term pregnancies (OR 0.3, CI95% 0.1–0.8). A
progressively increasing risk was identified in overweight
(OR 1.42, CI95% 1.07–1.86) and obese women (OR 1.96,
CI95% 1.40–2.74). Women from Indian Subcontinent,
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North and Sub-Saharan Africa presented a higher risk of
SB than Caucasian and above all Sub-Saharan Africa
women had an almost tripled risk (OR 2.9, CI95% 1.94–
4.35). Finally, women who had a previous SB carried a
greater risk of recurrence (OR 2.62, CI95% 1.34–5.14).
The risk was not significantly increased for smoking in
pregnancy, multiple gestations, maternal age and
education.
Table 2 shows the distribution of causes of death in
our cohort. The Regional Audit Program reviewed all
cases previously evaluated by local groups and estab-
lished a different cause of death in 54 (16.4%) cases. Dis-
agreement on the causes of death between local and
central committees were more frequent during the first
year of the project and progressively reduced in the fol-
lowing years, when local committees improved their
ability in interpreting the results of the investigations
and classifying the cause of deaths, thanks to discussions
during the meetings (data not shown). Placental disor-
ders were the most frequent relevant condition (33.3%),
followed by the fetus (17.6%), cord (14.2%) and maternal
disorders (7.6%). Forty-seven (14.2%) cases remained un-
explained even though the diagnostic protocol had been
carried out. However, it was not possible to assign a
cause of death in 14 cases (4.2%) because the diagnostic
work-up was incomplete.
Associated relevant conditions at death were found in
329 cases and the most frequent one was FGR which
was ascertained in 49 cases (14.9%).
For multivariate analysis, relevant conditions at death
have been categorized in seven groups: placental disorders
(110 cases), unexplained (61 cases), cord accidents (45
cases), infections (including proven fetal infection, histo-
logic funisitis and chorioamnionitis −39 cases-), fetal dis-
orders (38 cases), maternal disorders (25 cases) and others
(12 cases).
Infections were associated with early intrauterine fetal
death (OR 3.38, CI95% 1.62–7.03) while placental disor-
ders were related to preterm SB (OR 1.86, CI95% 1.11–
3.15) and FGR (OR 1.89, CI95% 1.06–3.36). Further-
more, maternal disorders were associated with over-
weight (OR 3.38, CI95% 1.33–8.6) and LGA (OR 4.26,
CI95% 1.07–12.87).
No significant association was found between causes
of death and smoking (although abruptio was more fre-
quent in this group), level of education, multiple preg-
nancies and maternal country of birth, even though
women from Indian Subcontinent had a high proportion
of SB due to placental disease (48%).
The quality of care provided during pregnancy and
labour has been assessed as shown in Table 3. Elements
of substandard care were present in 48 (14.5%) cases. A
different management might have made or would have
reasonably made a difference to outcome in 36 (10.9%)
cases. Elements of sub-optimal care were identified only
in antepartum cases. The first cause of death among
such cases was placental insufficiency (30.5%), followed
by maternal disorders -diabetes, hypertension disorders,
antiphospholipid syndrome- (25%). At multivariate ana-
lysis the group of maternal disorders was associated with
substandard care of grade 2 and 3 (OR 6.64, CI95%
2.61–17.02). No significant association has been found
Table 1 Risk factors for stillbirth compared to live births
Risk factors Live birthsa (number) Stillbirthsa (number) Rate (‰) OR CI95%
Gestational age category (weeks)
39–40 55,975 54 1.0 reference
≥ 41 17,262 5 0.3 0.3 0.1–0.8
Pregestational Maternal BMI (kg/m2)
18–24 67,268 171 2.5 reference
25–29 19,011 68 3.6 1.42 1.07–1.86
≥ 30 8620 43 5.0 1.96 1.40–2.74
Maternal nationality
Italy 73,854 190 2.6 reference
East Europe 13,820 34 2.5 0.96 0.66–1.38
North Africa 7690 38 4.9 1.6 1.35–2.72
Indian Subcontinent 3752 25 6.6 2.6 1.70–3.94
Sub-Saharan Africa 3616 27 7.4 2.9 1.94–4.35
Stillbirth recurrence
No previous stillbirth 48,574 194 4.0 reference
Previous stillbirth 859 9 10.4 2.62 1.34–5.14
a data from Regional Birth Register
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for the remaining causes of death. Eleven women
(30.5%) had a delayed access to antenatal care or missed
the antenatal appointments because ignored their preg-
nancy or either refused hospitalisation. In 9 cases (25%)
clinicians failed to diagnose or manage diabetes or
hypertensive disorders. Six cases (16.6%) affected by fetal
growth restriction were either not detected or managed
inappropriately. In 9 cases different suboptimal care
factors were identified, e.g. entering the pregnancy with
an elevated BMI or continuing smoking during
pregnancy.
Among the 9 cases evaluated of grade 3, seven oc-
curred in racial minorities and only 2 in Italian women.
Figure 1 shows the distribution of women’s country of
birth in relation to quality of care grading. The majority
of cases without substandard care occurred in Italian
Table 2 Distribution of causes of death according to ReCoDe classification
Relevant condition at death N % %
Group A: Fetus Lethal congenital anomaly 16 4.8 17.6
Infection 20 6.1
Non immune hydrops 1 0.3
Isoimmunisation 2 0.6
Fetomaternal haemorrhage 6 1.8
Twin-twin transfusion 2 0.6
Fetal growth restriction 11 3.3
Group B: Cord Constricting loop or knot 20 6.1 14.2
Velamentous insertion 1 0.3





Group C: Placenta Abruptio 47 14.2 33.3
Placental insufficiency 56 17.0
Placenta: other 7 2.1
Gruppo D: Amniotic fluid Chorioamnionitis 19 5.8 5.8
Group E: uterus Rupture 6 1.8 1.8
Group F: Mother Diabetes 13 3.9 7.6
Essential hypertension 2 0.6
Hypertensive disorders in pregnancy 9 2.7
Lupus or antiphospholipid syndrome 1 0.3
Group G: Intrapartum Asphyxia 3 0.9 0.9
Group H: Trauma External 1 0.3 0.3
Group I: Unclassified No relevant condition identified 47 14.2 18.5
No information available 14 4.2
TOTAL 330 100.0 100.0
Table 3 Quality of care during pregnancy and labour according to CESDI grade
Grade Number (%)
Grade 0 no substandard care 260 (78.8)
Grade 1 substandard care, different management would have made no difference to outcome 12 (3.6)
Grade 2 substandard care, different management might have made a difference to outcome 27 (8.2)
Grade 3 substandard care, different management would have reasonably been expected to have made a difference to outcome 9 (2.7)
data not available 22 (6.7)
Total 330 (100)
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women, while most preventable stillbirths (grade 3) oc-
curred in migrant women born in other countries.
The leading cause of death in intrapartum SB was in-
fection (41.1%), followed by asphyxia (11.8%), uterine
rupture (11.8%) and others (17.7%). Unexplained cases
were 17.6%. Among the seven intrauterine fetal deaths
caused by infection, 5 occurred before 28 weeks. At lo-
gistic regression, intrapartum SB were associated with
infections (OR 7.15, CI95% 2.35–21.77), while there was
no association with inadequate care (grade 2 and 3).
Discussion
The audit process allowed a more realistic evaluation of
stillbirth phenomenon, highlighting the underestimation
of early SB, due to the present Italian law which defines
miscarriage as products of conception prior to 180 days
of development (25 weeks and 5 days). Thus, we ex-
plained the discrepancy of 21 SB recorded in the audit
process, and not in the Birth Register, with the fact that
stillbirths occurred between 22 weeks and 25 weeks and
5 days were registered as miscarriage, according to the
Italian law, instead of using WHO’s definition for
stillbirths.
Late SB rate in ER was one of the lowest rates in Eur-
ope after Iceland, Denmark, Finland, the Netherlands,
Croatia, Norway and Portugal [4].
Most of the risk factors for SB known in literature are
confirmed by our study - overweight/obesity [22], racial
disparity [2, 4] and previous SB - [23–25]. On the other
hand, while post-term pregnancy is widely recognized as
a condition of higher risk for SB [26], this is not con-
firmed in our population where the risk decreased after
41 weeks compared to 39–40 weeks and no fetal death
occurred after 42 weeks. We hypothesized that such
finding could be related to the strict surveillance of
pregnancies above term in our Region. Indeed, there is a
weekly monitoring and scheduled induction for
pregnancies with medical indications, like gestational
diabetes, hypertensive disorders and late term pregnancy
(> 41 weeks) [27–29].
Placental disorders were the leading cause of death in
our cohort and explained one-third of stillbirths in line
with other authors which reported placental dysfunction
as a major contributor [30–32]. Moreover, fetal disorders
were responsible for about one case out of six and FGR
was the principal relevant condition at death in only 3%
of cases. Such frequency is much lower than the one re-
ported by Vergani et al. (17%) [16] with the same classi-
fication system. When we attributed the relevant
condition at death, we considered placental disorders as
a logic antecedent of FGR and then SB, believing that
growth restriction could be the cause of death only in
the absence of other conditions. Indeed, considering also
the associated factors, the whole rate of FGR (14.9%)
was similar to the one in Vergani’s group. Our results
are in general agreement with those of Ego et al. [33]
who previously adopted the same logic to classify cause
of stillbirths with ReCoDe, i.e. the incidence of placental
causes doubled becoming almost 25% when FGR was
considered as a cause only in the absence of other
conditions.
Infections are another significant cause of death,
counting for almost 12%. This is particularly true for
early SB as previously reported by other authors [34, 35].
On the other hand, the Audit System could not ex-
plain a significant number of cases (about one case out
of seven). This rate was close to those previously re-
ported by English [15], Italian [16] and Dutch [31] stud-
ies. Therefore, despite the existence of different
classification systems [10], a consistent number of SB re-
mains unexplained.
It is important to underline that the diagnostic workup
was performed in every hospital, limiting unexplained
stillbirths due to lack of investigation to < 5%. At the
Fig. 1 Distribution of women’s country of birth in relation to quality of care
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same time, placental pathology and fetal autopsy were
extensively carried out.
Based on current guidelines, substandard care factors
were identified by the multidisciplinary panel in a signifi-
cant number of cases where a different management
might have made a difference to outcome or would have
reasonably been expected to have made a difference to
outcome. In high-income countries, few perinatal audits
evaluated the quality of care in relation to SB. A national
audit in the Netherlands identified such inappropriate-
ness in 8% of more than 700 term perinatal deaths [9].
Also a review in New Zealand identified that up to 15%
of deaths are potentially avoidable [8]. The Euronatal
study [36], which included quality of care evaluation in
10 European regions between 1993 and 1998, found an
even higher percentage of sub-standard care factors than
previously reported. It seems likely that the above differ-
ences could be partly explained by quality of care im-
provement during the past 20 years.
In our study, the main issues recognised as areas for
improvement in antenatal care provision included the
access to antenatal care for disadvantages minorities and
the identification and management of maternal disor-
ders. Indeed, almost all cases with quality of care graded
3 occurred in women with poor access to antenatal care,
also because of unintended pregnancies. This confirms
that negative outcome did not always depend on care of-
fered but pertained to very disadvantaged minorities.
Therefore, it is mandatory to increase early access to the
antenatal care system in the effort to minimize racial
and ethnic disparities.
Furthermore, the association between the presence of
maternal disorders and inadequate care should stimulate
actions looking at the improvement of the management
of high-risk pregnancies. Improving detection and man-
agement of metabolic and hypertensive disorders, seems
of paramount importance also in reviewing the correl-
ation between SB-related maternal disorders and over-
weight/obesity.
As expected in western countries [2], intrapartum
cases were limited to 5% and were associated with ap-
propriate care in the vast majority of the cases. At logis-
tic regression, such deaths were associated with
infections, namely before 28 weeks, as also reported by
others [32]. Indeed, it is possible that infections may
have induced preterm labour and determined fetal death
because of extremely premature labour.
A limitation of the audit system is that it is time con-
suming. Another one is that despite the presence of
multidisciplinary professionals, there is no external val-
idation. Furthermore, histological exams were performed
locally by different pathologists whose expertise in peri-
natal pathology was heterogenous. The importance of
placental pathology, confirmed also by our work,
supports the importance of having pathologists trained
and specialized in perinatal pathology. Moreover, deaths
occurring in the first neonatal week were not included.
Finally, we do not have sufficient data to assess the im-
pact of the validity of each investigation.
This study has several strengths. Comparison between
cases detected by the audit project and current Birth
Register led to a precise counting of each and every SB.
Moreover, a homogeneous work-up was performed and
information was prospectively collected, ensuring a high
quality of data which is difficult to reach in large data-
base. Moreover, causes of death were assigned by con-
sensus among multidisciplinary panel of experts in
maternal-fetal medicine and this guaranteed a high ac-
curacy results.
Conclusions
These data demonstrate that it is possible to implement
a Regional Audit System of Stillbirth as recommended
by international institutions [37]. Overall results are use-
ful to understand local reality, in order to plan interven-
tions towards specific populations.
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